168 related articles for article (PubMed ID: 14659814)
21. Comparison of neointimal hyperplasia with drug-eluting stents versus bare metal stents in patients undergoing intracoronary bone-marrow mononuclear cell transplantation following acute myocardial infarction.
Villa A; Arnold R; Sánchez PL; Gimeno F; Ramos B; Cantero T; Fernández ME; Sanz R; Gutiérrez O; Mota P; García-Frade J; San Román JA; Fernández-Avilés F;
Am J Cardiol; 2009 Jun; 103(12):1651-6. PubMed ID: 19539071
[TBL] [Abstract][Full Text] [Related]
22. Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial.
Chaves AJ; Sousa AG; Mattos LA; Abizaid A; Staico R; Feres F; Centemero M; Tanajura LF; Abizaid A; Pinto I; Maldonado G; Seixas A; Costa MA; Paes A; Mintz GS; Sousa JE
Circulation; 2004 Feb; 109(7):861-6. PubMed ID: 14757690
[TBL] [Abstract][Full Text] [Related]
23. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study.
Pelliccia F; Cianfrocca C; Rosano G; Mercuro G; Speciale G; Pasceri V
JACC Cardiovasc Interv; 2010 Jan; 3(1):78-86. PubMed ID: 20129574
[TBL] [Abstract][Full Text] [Related]
24. A paclitaxel-eluting stent for the prevention of coronary restenosis.
Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
[TBL] [Abstract][Full Text] [Related]
25. Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study.
Nunes GL; Abizaid AC; Theodoro MP; Brito FS; Caixeta A; da Silva LF; Mazzotti NG; Belló-Klein A; Clausell N
Am Heart J; 2006 Nov; 152(5):914.e1-7. PubMed ID: 17070157
[TBL] [Abstract][Full Text] [Related]
26. Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation.
Yoneda S; Abe S; Kanaya T; Oda K; Nishino S; Kageyama M; Taguchi I; Masawa N; Inoue T
Coron Artery Dis; 2013 Aug; 24(5):368-73. PubMed ID: 23744617
[TBL] [Abstract][Full Text] [Related]
27. Images in cardiovascular medicine. In-stent neointimal hyperplasia with 16-row multislice computed tomography coronary angiography.
Mollet NR; Cademartiri F
Circulation; 2004 Nov; 110(21):e514. PubMed ID: 15557383
[No Abstract] [Full Text] [Related]
28. Mechanisms of restenosis after coronary intervention: difference between plain old balloon angioplasty and stenting.
Nakatani M; Takeyama Y; Shibata M; Yorozuya M; Suzuki H; Koba S; Katagiri T
Cardiovasc Pathol; 2003; 12(1):40-8. PubMed ID: 12598017
[TBL] [Abstract][Full Text] [Related]
29. In-stent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-elevation myocardial infarction (STEMMI Trial).
Jørgensen E; Ripa RS; Helqvist S; Wang Y; Johnsen HE; Grande P; Kastrup J
Int J Cardiol; 2006 Jul; 111(1):174-7. PubMed ID: 16054717
[TBL] [Abstract][Full Text] [Related]
30. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M
Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731
[TBL] [Abstract][Full Text] [Related]
31. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
[No Abstract] [Full Text] [Related]
32. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
[TBL] [Abstract][Full Text] [Related]
33. Eosinophilic infiltration in restenotic tissue following coronary stent implantation.
Rittersma SZ; Meuwissen M; van der Loos CM; Koch KT; de Winter RJ; Piek JJ; van der Wal AC
Atherosclerosis; 2006 Jan; 184(1):157-62. PubMed ID: 15950231
[TBL] [Abstract][Full Text] [Related]
34. Levels of circulating CD34+/KDR+ cells do not predict coronary in-stent restenosis.
Haine SE; Van Craenenbroeck EM; Hoymans VY; Miljoen HP; Vandendriessche TR; Claeys MJ; Frederix G; Conraads VM; Bosmans JM; Vrints CJ
Can J Cardiol; 2014 Jan; 30(1):102-8. PubMed ID: 24365195
[TBL] [Abstract][Full Text] [Related]
35. Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotic lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study.
Takagi T; Yamamuro A; Tamita K; Katayama M; Morioka S
J Cardiol; 2005 Apr; 45(4):139-47. PubMed ID: 15875535
[TBL] [Abstract][Full Text] [Related]
36. Non-bone marrow origin of neointimal smooth muscle cells in experimental in-stent restenosis in rats.
Groenewegen HC; Onuta G; Goris M; Zandvoort A; Zijlstra F; van Gilst WH; Rozing J; de Smet BJ; Roks AJ; Hillebrands JL
J Vasc Res; 2008; 45(6):493-502. PubMed ID: 18434748
[TBL] [Abstract][Full Text] [Related]
37. Effects of candesartan and probucol on restenosis after coronary stenting: results of insight of stent intimal hyperplasia inhibition by new angiotensin II receptor antagonist (ISHIN) trial.
Wakeyama T; Ogawa H; Iida H; Takaki A; Iwami T; Mochizuki M; Tanaka T
Circ J; 2003 Jun; 67(6):519-24. PubMed ID: 12808270
[TBL] [Abstract][Full Text] [Related]
38. Neointimal hyperplasia after stenting in a human mammary artery organ culture.
Guérin P; Rondeau F; Grimandi G; Heymann MF; Heymann D; Pillet P; Al Habash O; Loirand G; Pacaud P; Crochet D
J Vasc Res; 2004; 41(1):46-53. PubMed ID: 14730201
[TBL] [Abstract][Full Text] [Related]
39. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy.
Sera F; Awata M; Uematsu M; Kotani J; Nanto S; Nagata S
JACC Cardiovasc Interv; 2009 Oct; 2(10):989-94. PubMed ID: 19850260
[TBL] [Abstract][Full Text] [Related]
40. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial.
Hausleiter J; Kastrati A; Mehilli J; Vogeser M; Zohlnhöfer D; Schühlen H; Goos C; Pache J; Dotzer F; Pogatsa-Murray G; Dirschinger J; Heemann U; Schömig A;
Circulation; 2004 Aug; 110(7):790-5. PubMed ID: 15302787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
